Herrera VL[au] - Search Results

Year	Number of Results
1987	2
1988	2
1990	2
1991	1
1992	1
1993	1
1994	6
1995	1
1997	3
1998	4
1999	1
2001	4
2002	1
2003	4
2004	4
2005	5
2006	2
2007	3
2008	2
2009	4
2010	3
2011	5
2012	4
2013	6
2014	3
2015	4
2016	4
2017	2
2018	1
2020	2
2021	6
2022	2

1

The size and culturability of patient-generated SARS-CoV-2 aerosol.

Santarpia JL, Herrera VL, Rivera DN, Ratnesar-Shumate S, Reid SP, Ackerman DN, Denton PW, Martens JWS, Fang Y, Conoan N, Callahan MV, Lawler JV, Brett-Major DM, Lowe JJ. Santarpia JL, et al. Among authors: herrera vl. J Expo Sci Environ Epidemiol. 2021 Aug 18:1-6. doi: 10.1038/s41370-021-00376-8. Online ahead of print. J Expo Sci Environ Epidemiol. 2021. PMID: 34408261 Free PMC article.

2

DEspR^high neutrophils are associated with critical illness in COVID-19.

deKay JT, Emery IF, Rud J, Eldridge A, Lord C, Gagnon DJ, May TL, Herrera VLM, Ruiz-Opazo N, Riker RR, Sawyer DB, Ryzhov S, Seder DB. deKay JT, et al. Among authors: herrera vlm. Sci Rep. 2021 Nov 17;11(1):22463. doi: 10.1038/s41598-021-01943-7. Sci Rep. 2021. PMID: 34789851 Free PMC article.

3

Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells.

Herrera VL, Colby AH, Ruiz-Opazo N, Coleman DG, Grinstaff MW. Herrera VL, et al. Nanomedicine (Lond). 2018 Aug;13(16):2083-2098. doi: 10.2217/nnm-2018-0122. Epub 2018 Sep 11. Nanomedicine (Lond). 2018. PMID: 30204054 Free PMC article. Review.

4

Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care.

Santarpia JL, Rivera DN, Herrera VL, Morwitzer MJ, Creager HM, Santarpia GW, Crown KK, Brett-Major DM, Schnaubelt ER, Broadhurst MJ, Lawler JV, Reid SP, Lowe JJ. Santarpia JL, et al. Among authors: herrera vl. Sci Rep. 2020 Jul 29;10(1):12732. doi: 10.1038/s41598-020-69286-3. Sci Rep. 2020. PMID: 32728118 Free PMC article.

5

Humanized anti-DEspR IgG4^S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis rat^nu/nu model.

Gromisch CM, Tan GLA, Pasion KA, Moran AM, Gromisch MS, Grinstaff MW, Carr FJ, Herrera VLM, Ruiz-Opazo N. Gromisch CM, et al. Among authors: herrera vlm. BMC Cancer. 2021 Apr 14;21(1):407. doi: 10.1186/s12885-021-08107-w. BMC Cancer. 2021. PMID: 33853558 Free PMC article.

6

Aerosol tracer testing in Boeing 767 and 777 aircraft to simulate exposure potential of infectious aerosol such as SARS-CoV-2.

Kinahan SM, Silcott DB, Silcott BE, Silcott RM, Silcott PJ, Silcott BJ, Distelhorst SL, Herrera VL, Rivera DN, Crown KK, Lucero GA, Santarpia JL. Kinahan SM, et al. Among authors: herrera vl. PLoS One. 2021 Dec 1;16(12):e0246916. doi: 10.1371/journal.pone.0246916. eCollection 2021. PLoS One. 2021. PMID: 34851965 Free PMC article.

7

Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target.

Herrera VLM, Walkey AJ, Nguyen MQ, Gromisch CM, Mosaddhegi JZ, Gromisch MS, Jundi B, Lukassen S, Carstensen S, Denis R, Belkina AC, Baron RM, Pinilla-Vera M, Muller M, Kimberly WT, Goldstein JN, Lehmann I, Shih AR, Eils R, Levy BD, Ruiz-Opazo N. Herrera VLM, et al. Res Sq. 2021 Sep 13:rs.3.rs-846250. doi: 10.21203/rs.3.rs-846250/v1. Preprint. Res Sq. 2021. PMID: 34545358 Free PMC article.

8

Genetic studies in rat models: insights into cardiovascular disease.

Herrera VL, Ruiz-Opazo N. Herrera VL, et al. Curr Opin Lipidol. 2005 Apr;16(2):179-91. doi: 10.1097/01.mol.0000162323.77666.5e. Curr Opin Lipidol. 2005. PMID: 15767858 Review.

9

Implementation of a COVID-19 cohort area resulted in no surface or air contamination in surrounding areas in one academic emergency department.

Barksdale AN, Zeger WG, Santarpia JL, Herrera VL, Ackerman DN, Lowe JJ, Wadman MC. Barksdale AN, et al. Among authors: herrera vl. Am J Emerg Med. 2021 Sep;47:253-257. doi: 10.1016/j.ajem.2021.04.082. Epub 2021 Apr 30. Am J Emerg Med. 2021. PMID: 33965895 Free PMC article.

10

Perspectives on adipose-derived stem/stromal cells as potential treatment for scarred vocal folds: opportunity and challenges.

Kumai Y, Kobler JB, Herrera VL, Zeitels SM. Kumai Y, et al. Among authors: herrera vl. Curr Stem Cell Res Ther. 2010 Jun;5(2):175-81. doi: 10.2174/157488810791268591. Curr Stem Cell Res Ther. 2010. PMID: 19941448 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results